Products for Research Use Only

Tofacitinib Citrate

CAT: 0013-GTR19174937-02Size: 1 ml x 10 mM (in DMSO)Dry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19174937-02Size:1 ml x 10 mM (in DMSO)
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tofacitinib citrate is a potent and cell-permeable Janus kinase (JAK) inhibitor with selectivity for JAK1, JAK2, and JAK3. It is widely used in both in vitro and in vivo research to investigate JAK-STAT signaling pathways in immunology, inflammation, and autoimmune disease models.
CAS Number
540737-29-9
Product Name Alternative
Tofacitinib, Tofacitinib (CP-690550) Citrate, Tofacitinib Citrate, Tasocitinib, Tasocitinib citrate, Tasocitinib Citrate, JAK1, JAK2, JAK, Janus kinase, JAK3, inhibit, InfluenzaVirus, Influenza Virus, Fungal, Inhibitor, CP690550, CP-690550, CP690550 Citrate, CP-690550 Citrate, CP-690550 citrate, CP 690550, CP 690550 Citrate, Apoptosis, Bacterial
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Infectious Disease & Virology, Pharmacology & Drug Discovery, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.19% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.96 mM) ; DMSO:55 mg/mL (109.02 mM)
Smiles
OC (=O) CC (O) (CC (O) =O) C (O) =O.C[C@@H]1CCN (C[C@@H]1N (C) c1ncnc2[nH]ccc12) C (=O) CC#N
Molecular Formula
C22H28N6O8
Molecular Weight
504.49
Storage Conditions
-20°C
Notes
For research use only.

Chemical Information

Tofacitinib Citrate

Tofacitinib citrate is a citrate salt obtained by combining equimolar amounts of tofacitinib and citric acid. Used to treat moderately to severely active Rheumatoid Arthritis. It has a role as an antirheumatic drug and an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor. It contains a tofacitinib.

CAS Number540737-29-9
PubChem CID10174505
IUPAC Name2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
Molecular FormulaC22H28N6O8
Molecular Weight504.5
Topological Polar Surface Area221
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count12
Rotatable Bond Count8
Heavy Atom Count36
Formal Charge0
Complexity716
SMILES
C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
InChI
InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1
InChIKey
SYIKUFDOYJFGBQ-YLAFAASESA-N
Chemical Structure
2D Structure
2D structure of Tofacitinib Citrate
CAS: 540737-29-9
CID: 10174505
Formula: C22H28N6O8
MW: 504.5
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight504.5
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count12
Rotatable Bond Count8
Exact Mass504.19686187
Monoisotopic Mass504.19686187
Topological Polar Surface Area221 Ų
Heavy Atom Count36
Formal Charge0
Complexity716
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes